2 terminated, 2 withdrawn, 1 recruiting. 4 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Withdrawn 2 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Austin V Stone: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair Fisetin, Placebo oral capsule - Meniscus Tear, Meniscus; Derangement | Phase 2 / Phase 3 | Withdrawn | Austin V Stone | 2025-07-01 | 2025-05-08 | |
| Targeting Senescence to Reduce Osteoarthritis Pain and cartilagE Breakdown (ROPE) High-dose/short-duration Fisetin, Low-dose/sustained-duration Fisetin, Oral placebo capsule - Osteoarthritis, Knee | Phase 1 / Phase 2 | Withdrawn | Austin V Stone | 2023-06-01 | 2022-07-29 | |
| PROPER Trial of Pain and Inflammation After Knee Arthroscopy Ceftriaxone, Placebo - Meniscus Tear, Meniscus Lesion | Phase 2 | Terminated | Austin V Stone | 5 | 2021-12-28 | 2023-09-05 |
| MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) Montelukast, Placebo - ACL Injury, Meniscus Tear | Early Phase 1 | Recruiting | Austin V Stone | 30 | 2021-02-01 | 2026-06-10 |
| Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury Zilretta, Placebo - Tibial Meniscus Injuries, Tibial Meniscus Tears | Phase 2 | Terminated | Austin V Stone | 1 | 2020-08-21 | 2023-07-27 |
Anterior Cruciate Ligament Injuries (2) · Osteoarthritis (2) · Inflammation (1) · Osteoarthritis, Knee (1) · Pain (1) · Tibial Meniscus Injuries (1)
Sodium Chloride (2) · Ceftriaxone (1) · Lidocaine (1) · Triamcinolone (1) · fisetin (1) · montelukast (1)
United States (5)